Form 8-K - Current report:
SEC Accession No. 0001437749-25-010211
Filing Date
2025-03-31
Accepted
2025-03-31 16:25:19
Documents
16
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20241119_8k.htm   iXBRL 8-K 25740
2 EXHIBIT 99.1 ex_749944.htm EX-99.1 154047
7 logo.jpg GRAPHIC 5215
  Complete submission text file 0001437749-25-010211.txt   343987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA omer-20250331.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20250331_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250331_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250331_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT omer20241119_8k_htm.xml XML 2824
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 25793642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)